# Correction: Efficacy and safety of pegylated interferon in the treatment of JAK2V617F-positive polycythemia vera with a dose de-escalation strategy: a single-center retrospective study

**Authors:** Long Chang, Wen-Xin Li, Hao Cai, Jian Li, Ming-Hui Duan

PMC · DOI: 10.3389/fonc.2025.1641150 · Frontiers in Oncology · 2025-06-19

## Full-text entities

- **Diseases:** polycythemia vera (MESH:D011087)
- **Chemicals:** pegylated interferon (-)
- **Mutations:** JAK2V617F

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12224278/full.md

---
Source: https://tomesphere.com/paper/PMC12224278